Sjögren's disease

Otolaryngologic Clinics of North America

Volumn 36, Issue 4, 2003, Pages 733-745

  Mahoney, Elizabeth J ^a   Spiegel, Jeffrey H ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL TEAR; CEVIMELINE; MUSCARINIC RECEPTOR BLOCKING AGENT; PILOCARPINE; STEROID;

CLINICAL FEATURE; DRUG HALF LIFE; EYE DISEASE; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOMODULATION; KERATOCONJUNCTIVITIS SICCA; PATHOGENESIS; REVIEW; SIDE EFFECT; SJOEGREN SYNDROME; SWEATING; XEROSTOMIA;

EID: 0041802832     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0030-6665(03)00024-0     Document Type: Review

References (29)

1. Talal N. What is Sjogren's syndrome and why is it important? J Rheumatol 2000;27 (Suppl 61):1-2.
2. Lahita R. Sjogren's syndrome. In: Lahita R, Chiorazzi N, Reeves WH, editors. Textbook of autoimmune diseases. Philadelphia: Lippincott Williams & Wilkins; 2000:569-72.
3. Mariette X. Lymphomas complicating Sjogren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells. Ann Rheum Dis 2001;60(11):1007-10.
4. Lemp M. Evaluation and differential diagnosis of keratoconjunctivitis sicca. J Rheumatol 2000;27(Suppl 61):11-4.
5. Manoussakis M, Moutsopoulos H. Sjogren's syndrome: current concepts. Adv Intern Med 2001;47:191-217.
6. Daniels T. Evaluation differential diagnosis, and treatment of xerostomia. J Rheumatol 2000;27(Suppl 61):6-10.
7. Campbell S, Montanaro A, Bardana E. Head and neck manifestations of autoimmune disease. Am J Otolaryngol 1983;4:187-216.
8. Zandbelt M, Wentink J, de Wilde P, et al. The synergistic value of focus score and IgA% score of sublabial salivary gland biopsy for the accuracy of the diagnosis of Sjogren's syndrome: a 10-year comparison. Arthritis Rheum 2001;44(9 Suppl):S141.
9. Tumiati B, Casoli P, Parmeggiani A. Hearing loss in the Sjogren syndrome. Ann Intern Med 1997;126:450-3.
10. Boki K, Ioannidis J, Segas J, et al. How significant is sensorineural hearing loss in primary Sjogren's syndrome? An individually matched case-control study. J Rheumatol 2000; 28(4):798-801.
11. Murano E, Hosako-Naito Y, Tayama N, et al. Bamboo node: primary vocal fold lesion as evidence of autoimmune disease. J Voice 2001;15(3):441-50.
12. Prytz S. Vocal nodules in Sjogren's syndrome. J Laryngol Otol 1980;94:197-203.
13. Karsh J, Pavlidis N, Weintraub BD, et al. Thyroid disease in Sjogren's syndrome. Arthritis Rheum 1980;23(11):1326-9.
14. Marasini B, Casari S, Mazzocchi D, et al. Is thyroid testing recommended in connective tissue disease? Arthritis Rheum 2001;44(9 Suppl):S126.
15. Doig J, Whaley K, Dick W, et al. Otolaryngological aspects of Sjogren's syndrome. BMJ 1971;4:460-3.
16. Papiris SA, Maniati M, Constantopoulos SH, et al. Lung involvement in primary Sjogren's syndrome is mainly related to the small airway disease. Ann Rheum Dis 1999;58(1):61-4.
17. Skopouli FN, Barbatis C, Moutsopoulos HM. Liver involvement in primary Sjogren's syndrome. Br J Rheumatol 1994;33(8):745-8.
18. Manoussakis MN, Talal N, Moutsopoulos HM. Sjogren's syndrome. In: Rose N, McKay I, editors. The autoimmune diseases. 3rd edition. San Diego: Academic Press; 1998. p. 381-404.
19. Sankar V, Kok M, Leakan R, et al. The prevalence of urinary tract symptoms in patients with Sjogren's syndrome. Arthritis Rheum 2001;44(9 Suppl):S142.
20. Aoki A, Hagiwara E, Ohno S, et al. Myositis in primary Sjogren's syndrome: clinical, immunological and pathological report. Arthritis Rheum 2001;44(9 Suppl):S142.
21. Barendregt P, van den Bent M, van Raaij-van den Aarssen V, et al. Involvement of the peripheral nervous system in primary Sjogren's syndrome. Ann Rheum Dis 2001; 60(9):876-81.
22. Mariette X. Lymphomas in patients with Sjogren's syndrome: review of the literature and physiopathologic hypothesis. Leuk Lymphoma 1999;33(1-2):93-9.
23. Vitali C, Bombardieri S, Jonsson R, et al, and the European Study Group on Classification Criteria for Sjogren's Syndrome. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 2002;61(6):554-8.
24. Fox R, Stern M. Sjogren's syndrome: mechanisms of pathogenesis involve interaction of immune and neurosecretory systems. Scand J Rheumatol 2002;31(Suppl 116):3-13.
25. Fox R. Sjogren's syndrome: pathogenesis and approaches to therapy. In: Sullivan DA, Dartt DA, Meneray MA, et al, editors. Lacrimal gland, tear film and dry eye syndromes. New York: Plenum Press, 1998.
26. Saegusa K, Ishimaru N, Yanagi K, et al. Prevention and induction of autoimmune exocrinopathy is dependent on pathogenic autoantigen cleavage in murine Sjogren's syndrome. J Immunol 2002;169(2):1050-7.
27. Jonsson R, Hans-Jacob H, Gordon T. Current concepts on diagnosis, autoantibodies and therapy in Sjogren's syndrome. Scand J Rheumatol 2000;29:341-8.
28. Fox R, Stern M, Michelson P. Update in Sjogren syndrome. Curr Opin Rheumatol 2000; 12(5):391-8.
29. Fox R, Michelson P. Approaches to the treatment of Sjogren's syndrome. J Rheumatol 2000;27(Suppl 61):15-21.